260 related articles for article (PubMed ID: 12053473)
21. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors (GIST).
Sugár I; Forgács B; István G; Bognár G; Sápy Z; Ondrejka P
Hepatogastroenterology; 2005; 52(62):409-13. PubMed ID: 15816446
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
Rudolph P; Chiaravalli AM; Pauser U; Oschlies I; Hillemanns M; Gobbo M; Marichal M; Eusebi V; Höfler H; Capella C; Klöppel G
Virchows Arch; 2002 Sep; 441(3):238-48. PubMed ID: 12242520
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
27. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical review of stromal tumors in the gastrointestinal tract.
Nishida T; Hirota S
Histol Histopathol; 2000 Oct; 15(4):1293-301. PubMed ID: 11005253
[TBL] [Abstract][Full Text] [Related]
29. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters.
Doyle LA; Hornick JL; Fletcher CD
Am J Surg Pathol; 2013 Dec; 37(12):1769-82. PubMed ID: 24061520
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors of gastrointestinal stromal tumors of the stomach].
Hillemanns M; Päsold S; Böttcher K; Höfler H
Verh Dtsch Ges Pathol; 1998; 82():261-6. PubMed ID: 10095444
[TBL] [Abstract][Full Text] [Related]
31. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
[TBL] [Abstract][Full Text] [Related]
32. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications.
Vassos N; Agaimy A; Hohenberger W; Croner RS
Int J Surg; 2014; 12(5):371-7. PubMed ID: 24632413
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases.
Li CF; Chuang SS; Lu CL; Lin CN
Pathol Res Pract; 2005; 201(1):1-9. PubMed ID: 15807305
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features of small gastrointestinal stromal tumors].
Gao X; Xue A; Fang Y; Shu P; Ling J; Hu J; Hou Y; Shen K; Qin J; Sun Y; Qin X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Apr; 18(4):338-41. PubMed ID: 25940174
[TBL] [Abstract][Full Text] [Related]
37. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
38. The GIST paradigm: how to establish diagnostic and prognostic criteria.
Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
40. Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.
Machado NO; Chopra PJ; Al-Haddabi IH; Al-Qadhi H
JOP; 2011 Mar; 12(2):194-9. PubMed ID: 21386652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]